510(k) Report

510(k) · Cleared

Cleared

ABL90 FLEX PLUS System

K252488510(k) TraditionalCleared May 1, 2026266-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Radiometer Medicals Aps · CGA Glucose Oxidase, Glucose

Cleared on May 1, 2026 as substantially equivalent to K223755 (Abbott Point of Care, Inc., 2023) after a 266-day review. Its family tree reaches back 6 generations to 1988.

Decided
May 1, 2026
Review
266 days
Class
Class II
Product code
CGA
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K883181 (1988). 17 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK883181 Synchron CX4/CX5 Clinical Chemistry Analyzer ReageBeckman Instruments, Inc. · 1988 · Recalled
  2. 5 generations backK965240 Synchron LX 20 Clinical Chemistry System, Synchron LX Albumin…Beckman Instruments, Inc. · 1997 · Recalled
  3. 4 generations backK042291 Unicel DXC 600 and 800 Synchron SystemsBeckman Coulter, Inc. · 2004 · Recalled
  4. 3 generations backK183678 i-STAT CHEM8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc. · 2020
  5. 2 generations backK210958 i-STAT CHEM8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc. · 2021
  6. 1 generation backK223755 i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc. · 2023
  7. This deviceK252488 ABL90 FLEX PLUS SystemRadiometer Medicals Aps · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K883181Synchron CX4/CX5 Clinical Chemistry Analyzer ReageBeckman Instruments, Inc.19882
−5K965240Synchron LX 20 Clinical Chemistry System, Synchron LX Albumin Reagent…Beckman Instruments, Inc.199712
−4K042291Unicel DXC 600 and 800 Synchron SystemsBeckman Coulter, Inc.200434
−3K183678i-STAT CHEM8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2020—
−2K210958i-STAT CHEM8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2021—
−1K223755i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.2023—
0 (this device)K252488ABL90 FLEX PLUS SystemRadiometer Medicals Aps2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
200010
200110
200610
201110
201710
202040
FIG. 1 — Lineage of K252488, 1988–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CGA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGA device

  1. #1 K223755 i-STAT G cartridge with the i-STAT 1 Systemscore 10.2 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K223755i-STAT G cartridge with the i-STAT 1 System
Summary page 5
…Device Device Trade Name: i-STAT G Cartridge with the i-STAT 1 System Common Name: Glucose test, analyzer, handheld 510(k) K223755 Regulations: 21 CFR 862.1345, Glucose test system Product Codes: CGA Device Class: Clas…
Abbott Point of Care, Inc.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 38 years and passes through 4 companies; a new generation was cleared every 7.7 years on median.
  • 7 of the 17 ancestors have a recall of any class.

How does its category compare?

All CGA devices

CGA Glucose Oxidase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · CGA

2in 2024

2007: 72008: 62009: 102010: 82011: 92012: 102013: 32014: 52015: 42016: 42017: 22018: 22019: 22020: 22021: 12022: 12023: 42024: 22026 (partial year): 1
2007high 10 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGA

249in 2023

2007: 122 days median2008: 56 days median2009: 155 days median2010: 122 days median2011: 217 days median2012: 123 days median2013: 441 days median2014: 265 days median2015: 150 days median2016: 157 days median2023: 249 days median
2007high 441 (2013) · low 56 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGA

3in 2023

2007: 22008: 22009: 42010: 62011: 32013: 32014: 22015: 6, 2 Class I2016: 22019: 12023: 3
2007high 6 (2010) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CGA

59in 2025

2007: 292008: 372009: 752010: 1722011: 4232012: 2332013: 1722014: 1222015: 1552016: 362017: 922018: 692019: 1162020: 682021: 482022: 2722023: 1,1412024: 2662025: 59
2007high 1,141 (2023) · low 29 (2007)2025

MAUDE reports naming product code CGA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077122229
2008656237
200910155475
201081226172
201192173423
2012101230233
201334413172
201452652122
201541506 (2)155
20164157236
20172—092
20182—069
20192—1116
20202—068
20211—048
20221—0272
2023424931,141
20242—0266
20250—059
20261—0—

What is it indicated for?

The ABL90 FLEX PLUS System is an in vitro diagnostic, portable, automated analyzer that quantitatively measures:

-glucose in heparinized capillary whole blood.

The ABL90 FLEX PLUS System is intended for use by trained technologists, nurses, physicians and therapists. It is

intended for use in a laboratory environment, near patient, or point-of-care setting.

These tests are only performed under a physician's order.

Glucose (cGlu): Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders

including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252488: ABL90 FLEX PLUS System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252488

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026